Buprenorphine - A Slice of the Pie (This activity meets the content requirements of the MATE Act)

Wednesday, July 19, 2023, 9:00 AM - Sunday, June 14, 2026, 11:00 PM

Presented Dr. Joyce Troxler, Director of Quillen College of Medicine’s Addiction Fellowship, on 2/22/23 for I AM (Interdisciplinary Addiction Medicine) ECHO. Presentation includes the scope of the opioid use disorder problem, MAT in the Emergency Department, Buprenorphine formulations and mechanism of action, and advantages and disadvantages of Buprenorphine in the treatment of opioid use disorder. 

This activity meets the content requirements of the MATE Act.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

1. Review addiction identification and evidence-based treatments.
2. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
3. Discuss other approved antagonist and agonist medications to treat OUD.
4. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.

 

Quillen College of Medicine, East Tennessee State University, designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

You are not logged in.

Please click the button below to login or create a new account before continuing.

The East Tennessee State Quillen College of Medicine Department of Continuing Education for Health Professionals adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

East Tennessee State University Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.